1. Nusinersen: The First Option Beyond Supportive Care for Spinal Muscular Atrophy

   • Vikas Maharshi
   • Shazia Hasan

   Review Article 28 July 2017 Pages: 807 - 817

   

2. Interventions for Refractory Trigeminal Neuralgia: A Bayesian Mixed Treatment Comparison Network Meta-Analysis of Randomized Controlled Clinical Trials

   • Kannan Sridharan
   • Gowri Sivaramakrishnan

   Systematic Review 17 July 2017 Pages: 819 - 831

   

3. Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece

   • George Gourzoulidis
   • Georgia Kourlaba
   • Nikos Maniadakis

   Original Research Article 12 June 2017 Pages: 833 - 844

   

4. Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study

   • Yoshiyuki Hamamoto
   • Sachiko Honjo
   • Hiroyuki Koshiyama

   Original Research Article 17 June 2017 Pages: 845 - 852

   

5. Potential Role of Allopurinol in Preventing Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial

   • Zahra Ghelich Khan
   • Azita Hajhossein Talasaz
   • Arash Jalali

   Original Research Article 12 June 2017 Pages: 853 - 860

   

6. Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy Chinese Subjects

   • Chaoying Hu
   • Yijun Wang
   • Jingying Jia

   Original Research Article 10 July 2017 Pages: 861 - 871

   

7. Effect of Degarelix, a Gonadotropin-Releasing Hormone Receptor Antagonist for the Treatment of Prostate Cancer, on Cardiac Repolarisation in a Randomised, Placebo and Active Comparator Controlled Thorough QT/QTc Trial in Healthy Men

   • Håkan Olsson
   • Niclas Petri
   • Lars Grundemar

   Original Research Article Open access 28 June 2017 Pages: 873 - 879

   

8. Pharmacodynamics of Insulin Preparations Administered in Different Subcutaneous Injection Sites: Are There Differences Between Healthy Subjects Versus Diabetic Patients?

   • Nuggehally R. Srinivas

   commentary 08 June 2017 Pages: 881 - 884

9. Pharmacokinetic Properties of Fast-acting Insulin Aspart Administered in Different Subcutaneous Injection Regions: Response to the commentary by Nuggehally R. Srinivas

   • Tim Heise
   • Ulrike Hövelmann
   • Hanne Haahr

   COMMENTARY 08 June 2017 Pages: 885 - 887

10. Erratum to: Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study

    • Yuri Aleksandrovich Karpov
    • On behalf of the FORTISSIMO physicians

    Erratum 10 July 2017 Pages: 889 - 890